Martina T.
- Country
- Germany
- Department
- Klinikum Weiden Med. Klinik I
Research Overview
- Evaluation of Overall Survival in Metastatic Pancreatic Ductal Adenocarcinoma with SBP-101, Nab-Paclitaxel, and Gemcitabine Therapy
- Preoperative FOLFOX Versus Postoperative Risk-Adapted Chemotherapy in Locally Advanced Rectal Cancer: A Phase III Randomized Trial
- Efficacy and Safety of Atezolizumab with FLOT Versus FLOT Alone in Locally Advanced Resectable Esophagogastric Adenocarcinoma
Data & Insights
Has run more than one trial at 29 of 151 partner sites.
Specializations
Cardiovascular disease and lipoprotein(a)-targeted therapy
Martina Troppmann is involved in clinical research on atherosclerotic cardiovascular disease and broader cardiovascular disease, with a clear focus on therapies aimed at reducing major cardiovascular events. Her work includes interest in lipoprotein(a)-lowering strategies and event prevention in patients with established or elevated cardiovascular risk.
- Major adverse cardiovascular events
- Coronary heart disease
- Myocardial infarction
- Lipoprotein(a) reduction
The therapeutic area reflects active involvement in preventive cardiology and long-term cardiovascular risk modification.
Breast cancer and endocrine-based oncology
Her oncology research includes HR-positive, HER2-negative breast cancer, with attention to both early and advanced disease settings. The clinical focus extends to treatment strategies that combine endocrine therapy with targeted approaches in hormone receptor-driven breast cancer.
- Early breast cancer
- Advanced breast cancer
- Endocrine therapy
- CDK4/6-targeted treatment
This area highlights involvement in breast cancer care where hormone sensitivity and resistance remain central therapeutic concerns.
Urologic oncology and bladder cancer
Martina Troppmann is engaged in research for high-risk non-muscle invasive bladder cancer and high-risk localized or locally advanced prostate cancer. Her clinical interests include bladder-sparing and disease-control strategies in genitourinary malignancies, as well as treatment approaches for patients receiving radiation-based management in prostate cancer.
- Non-muscle invasive bladder cancer
- Prostate cancer
- Localized advanced disease
- Genitourinary oncology
The therapeutic emphasis is on improving control of urothelial and prostate malignancies with risk-adapted treatment options.
Hematologic malignancies
Her trial portfolio includes chronic lymphocytic leukemia, small lymphocytic lymphoma, and relapsed or refractory multiple myeloma. This indicates sustained involvement in hematologic cancer research across both lymphoid and plasma cell disorders, with interest in treatment selection for previously untreated and relapsed disease.
- Chronic lymphocytic leukemia
- Small lymphocytic lymphoma
- Multiple myeloma
- Relapsed or refractory disease
Her therapeutic interests span modern systemic approaches in blood cancers with unmet needs in disease control and durability of response.
Gastrointestinal oncology and colorectal cancer
Martina Troppmann is also active in colorectal cancer and upper gastrointestinal cancer research, including colon cancer stage II, rectal cancer, and locally advanced esophagogastric adenocarcinoma. Her work reflects interest in organ-preserving strategies, recurrence prevention, and perioperative treatment concepts in gastrointestinal malignancies.
- Colon cancer
- Rectal cancer
- Organ preservation
- Esophagogastric adenocarcinoma
This domain centers on improving surgical outcomes, disease-free survival, and treatment selection in advanced gastrointestinal cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.